How Retailers Apply For ARTG Inclusion: Step-By-Step Guide And Practical Tips

ARTG Inclusion

Inclusion of a therapeutic good in the Australian Register of Therapeutic Goods before legal supply in Australia unless an exemption or exclusion applies.

When a retailer decides to act as a sponsor or to partner with a sponsor to bring a therapeutic product into the Australian market, the ARTG inclusion process becomes a central compliance activity. The process varies by product type and risk class, but the operational steps, documentation and post‑market responsibilities share common features. This guide covers practical steps retailers need to know when pursuing inclusion.

Step 1 — Confirm Product Classification

Before preparing an ARTG application, classify the product correctly: is it a medicine (prescription or over‑the‑counter), a complementary/listed medicine, or a medical device? Classification determines the assessment route and supporting evidence required. Misclassification leads to incorrect submissions and delays.

Step 2 — Decide Who Will Be The Sponsor

The sponsor is the legal entity responsible for the ARTG entry and for meeting TGA obligations. Retailers can act as sponsors but must be ready to manage ongoing compliance. Many retailers instead obtain products from a supplier who is the sponsor and can provide the ARTG number and sponsor declarations.

Step 3 — Gather Required Evidence

Required documentation depends on classification:

• Registered Medicines: Clinical data, manufacturing documentation, stability, certified batch release, and quality systems evidence.
• Listed Medicines: Evidence the ingredients are permitted, manufacturing follows Good Manufacturing Practice (GMP) where applicable, and labels comply with TGA listing requirements.
• Medical Devices: Conformity assessment evidence, technical documentation, and for higher‑risk devices notified certification by an appropriate conformity assessment body.

Step 4 — Lodge The Application Through TGA Systems

Sponsors submit ARTG applications and post‑market notifications through the TGA’s electronic lodgement portals. Fees, forms and application types differ by product. Ensure you select the correct application pathway and pay applicable fees; incomplete applications slow approval.

Step 5 — Plan For Timelines And Fees

Timelines vary from days for some listed medicines (once administrative checks are complete) to many months for full registration of high‑risk medicines or devices that require detailed evaluation. Budget for application fees and potential consultancy costs for technical documentation, clinical assessments and GMP audits.

Step 6 — Implement Post‑Market Obligations

Once included on the ARTG the sponsor (or retailer acting as sponsor) must maintain compliance through post‑market monitoring, incident reporting, record‑keeping and periodic renewals where applicable. Rapid response plans for recalls and adverse event reporting are essential operational elements for retailers who are sponsors.

Practical Tips To Smooth The Process

• Work with experienced sponsors: If you are a retailer new to therapeutic goods, partner with an established sponsor who can handle regulatory submissions and maintain ARTG entries.
• Standardise supplier information: Require each supplier to provide ARTG numbers, sponsor details, and documentary evidence before onboarding products.
• Use checklists: Create internal checklists for labeling, advertising claims, and ARTG documentation to prevent non‑compliant listings.
• Budget for quality assurance: Expect to fund product testing, packaging updates, and potential GMP audits for manufacturers.

Example Flow For An Online Retailer Bringing In A New Device

1) Classify device and identify risk class. 2) Confirm supplier’s conformity assessment certificate and request ARTG entry. 3) If supplier is not sponsor, decide whether retailer will sponsor or require supplier to sponsor. 4) Submit ARTG application or obtain sponsor documentation. 5) Update online product listing to match ARTG claims and label information. 6) Monitor adverse events and maintain records.

When To Seek Professional Advice

Complex cases — novel therapeutics, combination products, or high‑risk devices — benefit from early regulatory advice or a consultant experienced with TGA submissions. Legal counsel can also help with commercial arrangements related to sponsorship, importation, and liability allocation between retailer and supplier.

In short, the ARTG Inclusion pathway is procedural and evidence‑based: retailers that treat the entry process as an operational project — with clear sponsorship roles, documentation standards, and post‑market systems — reduce time to market and avoid compliance risks when supplying therapeutic goods in Australia.